GeneMetrics has launched a fully customizable genomics platform designed to address fragmentation in the precision health market by unifying lifestyle, clinical, diagnostic, and advanced genetic testing into a single, cohesive solution. The platform aims to resolve challenges faced by health providers who currently must assemble incomplete solutions from multiple vendors, each with different constraints and limitations.
The genetics marketplace currently presents practitioners and companies with difficult choices between consumer-oriented kits that lack clinical depth and overly technical clinical platforms designed exclusively for specialists. Diagnostic and advanced testing solutions often operate as black-box systems with algorithms clients cannot control or verify. This fragmentation creates disjointed patient experiences involving multiple tests, registration portals, and contradictory interpretations that undermine trust in personalized health solutions.
GeneMetrics represents a departure from traditional white-label or private-label approaches by offering what the company describes as "limitless customization." Unlike services that merely rebrand existing products, GeneMetrics functions as a custom testing product development company where every aspect—from kit design and packaging to wet-lab testing and data reporting—can be tailored to client specifications. The platform features one of the largest libraries of report elements and scientific topics, with thousands of validated options enabling offerings ranging from simple to highly advanced.
Advanced sequencing capabilities include bead-chip genotyping arrays with approximately 1 million SNPs per chip, clinical-grade Whole Exome Sequencing (WES), clinical-grade Whole Genome Sequencing (WGS), PCR and PGx panels, and testing for epigenetics, blood, urine, saliva, and microbiomes. Clients can sequence and report on anything from a single SNP to hundreds of millions of variants, providing flexibility across consumer lifestyle kits, clinical diagnostics, and enterprise research applications.
The platform's fully customizable recommendation engine prioritizes supplements, diet, lifestyle modifications, or medications while emphasizing clarity over quantity. This approach aims to deliver actionable, prioritized recommendations that save practitioner interpretation time while avoiding overwhelming patients with excessive information. Early adopters have reported significant benefits, including a U.S.-based functional medicine practice reducing practitioner analysis time by 70 percent and a European health AI firm scaling from 500 to 50,000 users in under six months.
Scientific integrity forms a cornerstone of the GeneMetrics approach, with every methodology—from polygenic and monogenic risk assessments to pharmacogenomics, imputation, ancestry analysis, methylation studies, and multi-omic bioinformatics—thoroughly validated and fully auditable. The platform incorporates machine learning algorithms referencing over 140,000 peer-reviewed studies and features a dedicated auditing system described as the most transparent and audit-ready scientific solution available. A team of over 80 professionals, including more than 40 MDs, PhDs, bioinformaticians, and data scientists, supports these capabilities under guidance from a Medical and Science Advisory Board.
Data security and client control receive particular emphasis, with compliance standards including HIPAA, GDPR, SOC 2 Type 2, and ISO27001. Multi-layer encryption protects data using AES-256 for data at rest and TLS for data in transit with compartmentalized databases. Clients maintain 100 percent ownership of their data, with GeneMetrics neither selling nor utilizing client information. For transparency, the company provides live compliance policies and monitoring at https://trust.genemetrics.com.
GeneMetrics operates exclusively as a backend provider without consumer-facing branding or direct competition with clients, offering what it terms "confidentiality as a service." The company distinguishes itself from B2C, private-label, and wholesale models by positioning as the industry's sole fully auditable, infinitely customizable backend genomics platform. Competitive pricing starts below $100 per unit depending on selections, with wholesale rates described as consistently outperforming market competitors on a like-for-like basis.
Designed for rapid scalability from boutique clinics to large-scale genomics initiatives, the platform supports turn-key logistics management including kit manufacturing, co-packing, fulfillment, and data analysis. Capacity can scale almost overnight according to company statements. GeneMetrics was founded by a team of clinicians, scientists, and legal experts led by CEO Benji Rabhan, with the company serving as a trusted backend provider for genomics and health companies globally across multiple continents.
The platform represents a step toward what GeneMetrics describes as the future of precision health—proactive, integrated, and accessible at scale. By merging genetics, epigenetics, blood, microbiome, and lifestyle data into one cohesive ecosystem driven by AI and multi-omic bioinformatics, the company aims to facilitate a transition from reactive medicine to personalized, preventive care. More information about the company is available at https://genemetrics.com.
